Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
Combs SE, Kieser M, Rieken S, Habermehl D, Jäkel O, Haberer T, Nikoghosyan A, Haselmann R, Unterberg A, Wick W, Debus J. Combs SE, et al. Among authors: rieken s. BMC Cancer. 2010 Sep 6;10:478. doi: 10.1186/1471-2407-10-478. BMC Cancer. 2010. PMID: 20819220 Free PMC article. Clinical Trial.
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
Blattmann C, Oertel S, Schulz-Ertner D, Rieken S, Haufe S, Ewerbeck V, Unterberg A, Karapanagiotou-Schenkel I, Combs SE, Nikoghosyan A, Bischof M, Jäkel O, Huber P, Kulozik AE, Debus J. Blattmann C, et al. Among authors: rieken s. BMC Cancer. 2010 Mar 12;10:96. doi: 10.1186/1471-2407-10-96. BMC Cancer. 2010. PMID: 20226028 Free PMC article. Clinical Trial.
Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
Combs SE, Burkholder I, Edler L, Rieken S, Habermehl D, Jäkel O, Haberer T, Haselmann R, Unterberg A, Wick W, Debus J. Combs SE, et al. Among authors: rieken s. BMC Cancer. 2010 Oct 6;10:533. doi: 10.1186/1471-2407-10-533. BMC Cancer. 2010. PMID: 20925951 Free PMC article. Clinical Trial.
Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial.
Combs SE, Edler L, Burkholder I, Rieken S, Habermehl D, Jäkel O, Haberer T, Unterberg A, Wick W, Debus J, Haselmann R. Combs SE, et al. Among authors: rieken s. BMC Cancer. 2010 Nov 9;10:615. doi: 10.1186/1471-2407-10-615. BMC Cancer. 2010. PMID: 21062428 Free PMC article. Clinical Trial.
Assessment of early toxicity and response in patients treated with proton and carbon ion therapy at the Heidelberg ion therapy center using the raster scanning technique.
Rieken S, Habermehl D, Nikoghosyan A, Jensen A, Haberer T, Jäkel O, Münter MW, Welzel T, Debus J, Combs SE. Rieken S, et al. Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e793-801. doi: 10.1016/j.ijrobp.2010.12.018. Epub 2011 Feb 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 21300464
Outcome and prognostic factors of radiation therapy for medulloblastoma.
Rieken S, Mohr A, Habermehl D, Welzel T, Lindel K, Witt O, Kulozik AE, Wick W, Debus J, Combs SE. Rieken S, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e7-e13. doi: 10.1016/j.ijrobp.2010.12.042. Epub 2011 Feb 23. Int J Radiat Oncol Biol Phys. 2011. PMID: 21345611
200 results